These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 350514)

  • 21. Relationship of indole production and antibiotic susceptibility in the Klebsiella bacillus.
    Klein D; Spindler JA; Matsen JM
    J Clin Microbiol; 1975 Nov; 2(5):425-9. PubMed ID: 1194407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effectiveness of kanamycin and kanamycin/cephalothin against Klebsiella. Comparison with other antibiotics.
    Bulger RJ
    Ann Intern Med; 1967 Sep; 67(3):523-32. PubMed ID: 6042642
    [No Abstract]   [Full Text] [Related]  

  • 23. The growth curves of enterobacteriaceae and the estimation of L-forms under the influence of cephalosporin antibiotics.
    Ullmann U
    Zentralbl Bakteriol Orig A; 1977 Jun; 238(2):220-7. PubMed ID: 329618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals.
    Actor P; Uri JV; Guarini JR; Zajac I; Phillips L; Sachs CS; DeMarinis RM; Hoover JR; Weisbach JA
    J Antibiot (Tokyo); 1975 Jun; 28(6):471-6. PubMed ID: 238925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cephalothin and cefazolin in vitro antibacterial activity and pharmacokinetics in dogs.
    Petersen SW; Rosin E
    Vet Surg; 1995; 24(4):347-51. PubMed ID: 7571387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disk susceptibility studies with cefazolin and cephalothin.
    Actor P; Guarini J; Uri J; Dickson J; Pauls JF; Weisbach JA
    Antimicrob Agents Chemother; 1974 Jan; 5(1):63-7. PubMed ID: 4840450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of revised susceptibility breakpoints on bacteremia of Klebsiella pneumoniae: Minimum inhibitory concentration of cefazolin and clinical outcomes.
    Chuang CH; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):679-684. PubMed ID: 25442869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
    Shah PM; Stille W
    Arzneimittelforschung; 1978; 28(9):1539-41. PubMed ID: 383106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of salmonellae to eight antimicrobial agents.
    Nabbut NH; Barbour EK; Al-Nakhli HM
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(2):190-5. PubMed ID: 6280412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotic sensitivity of 139 strains of Listeria serotyped by the National Reference Center in 1983].
    Reynaud A; Espaze EP; Papin S; Courtieu AL
    Ann Microbiol (Paris); 1984; 135B(3):331-9. PubMed ID: 6442548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates.
    Bookstaver DA; Bland CM; Arroyo MA
    J Med Microbiol; 2015 Oct; 64(10):1170-1173. PubMed ID: 26219948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1066-9. PubMed ID: 938021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of selected bacteria to cefaclor.
    Valenti AJ; Andriole VT
    Yale J Biol Med; 1977; 50(5):465-9. PubMed ID: 341537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Present status of bacterial resistance to antibiotics and chemotherapeutic drugs and a tendency towards the development of resistance].
    Fritsche D; Schulz-Stübner A
    Dtsch Med Wochenschr; 1972 Dec; 97(51):1963-8. PubMed ID: 4404874
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibiotic resistnace and R factors in Klebsiella pneumoniae.
    van Rensburg LJ; de Kock MJ; van Rensburg AJ
    S Afr Med J; 1975 Oct; 49(45):1876-8. PubMed ID: 1103329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transferable antibiotic resistance in E. coli and Klebsiella pneumoniae.
    Chadwick P; Niell M
    Can Med Assoc J; 1973 Oct; 109(8):691-6. PubMed ID: 4583432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
    Greenberg RN; Bollinger M
    Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.